Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 222,000 | 217,600 | 168,700 | 209,300 | 163,300 |
| Marketable Securities | 12,400 | 7,400 | 13,500 | 14,900 | 9,200 |
| Receivables | 924,800 | 876,000 | 1,030,800 | 1,165,700 | 700,500 |
| Inventories | 885,100 | 870,400 | 904,600 | 889,400 | 679,400 |
| Income taxes - deferred | 189,200 | 184,600 | 164,500 | 168,100 | 165,900 |
| TOTAL | $2,441,500 | $2,319,900 | $2,408,600 | $2,569,700 | $1,840,300 |
| Non-Current Assets | |||||
| PPE Net | 708,000 | 727,800 | 733,700 | 713,700 | 703,200 |
| Investments And Advances | 70,900 | 71,700 | 66,400 | 71,300 | 69,800 |
| Intangibles | 3,316,800 | 3,380,200 | 3,635,500 | 3,321,900 | 3,576,800 |
| Other Non-Current Assets | 28,800 | 27,500 | 18,500 | 21,700 | 173,400 |
| TOTAL | $4,124,500 | $4,207,200 | $4,454,100 | $4,128,600 | $4,523,200 |
| Total Assets | $6,566,000 | $6,527,100 | $6,862,700 | $6,698,300 | $6,363,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 196,800 | 193,400 | 189,000 | 184,500 | 1,300 |
| Accounts payable and accrued liabilities | 1,343,200 | 1,307,300 | 1,301,300 | 1,535,400 | 975,500 |
| TOTAL | $1,555,600 | $1,530,700 | $1,578,600 | $1,839,500 | $1,017,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,023,800 | 1,098,700 | 1,163,800 | 848,500 | 1,152,300 |
| Deferred Revenues | 9,700 | 12,500 | 12,100 | 12,800 | 16,900 |
| aiOther Non-Current Liabilities | 99,500 | 114,000 | 146,400 | 152,300 | 203,000 |
| TOTAL | $1,320,500 | $1,436,200 | $1,624,300 | $1,296,300 | $1,858,300 |
| Total Liabilities | $2,876,100 | $2,966,900 | $3,202,900 | $3,135,800 | $2,875,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 127,757 | 127,646 | 127,409 | 127,165 | 127,158 |
| Common Shares | 500 | 500 | 500 | 400 | 500 |
| Retained earnings | 2,154,700 | 2,078,000 | 2,140,200 | 2,085,400 | 1,990,600 |
| Other shareholders' equity | -63,100 | -99,200 | -39,800 | -77,300 | -41,900 |
| TOTAL | $3,689,900 | $3,560,200 | $3,659,800 | $3,562,500 | $3,487,800 |
| Total Liabilities And Equity | $6,566,000 | $6,527,100 | $6,862,700 | $6,698,300 | $6,363,500 |